These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20221870

  • 1. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
    Cole TB, Jansen K, Park S, Li WF, Furlong CE, Costa LG.
    Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
    [Abstract] [Full Text] [Related]

  • 2. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.
    Jansen KL, Cole TB, Park SS, Furlong CE, Costa LG.
    Toxicol Appl Pharmacol; 2009 Apr 15; 236(2):142-53. PubMed ID: 19371602
    [Abstract] [Full Text] [Related]

  • 3. Paraoxonase 1 (PON1) status and substrate hydrolysis.
    Richter RJ, Jarvik GP, Furlong CE.
    Toxicol Appl Pharmacol; 2009 Feb 15; 235(1):1-9. PubMed ID: 19071155
    [Abstract] [Full Text] [Related]

  • 4. Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.
    Cole TB, Beyer RP, Bammler TK, Park SS, Farin FM, Costa LG, Furlong CE.
    Toxicol Sci; 2011 Sep 15; 123(1):155-69. PubMed ID: 21673326
    [Abstract] [Full Text] [Related]

  • 5. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.
    Cole TB, Walter BJ, Shih DM, Tward AD, Lusis AJ, Timchalk C, Richter RJ, Costa LG, Furlong CE.
    Pharmacogenet Genomics; 2005 Aug 15; 15(8):589-98. PubMed ID: 16007003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
    Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE.
    Pharmacogenetics; 2000 Dec 15; 10(9):767-79. PubMed ID: 11191881
    [Abstract] [Full Text] [Related]

  • 9. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.
    Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, Eskenazi B.
    Pharmacogenet Genomics; 2006 Mar 15; 16(3):183-90. PubMed ID: 16495777
    [Abstract] [Full Text] [Related]

  • 10. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
    Furlong CE.
    J Biochem Mol Toxicol; 2007 Mar 15; 21(4):197-205. PubMed ID: 17936934
    [Abstract] [Full Text] [Related]

  • 11. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
    Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE.
    Biomarkers; 2003 Mar 15; 8(1):1-12. PubMed ID: 12519632
    [Abstract] [Full Text] [Related]

  • 12. Gene-environmental interactions and organophosphate toxicity.
    Povey AC.
    Toxicology; 2010 Dec 30; 278(3):294-304. PubMed ID: 20156521
    [Abstract] [Full Text] [Related]

  • 13. Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.
    Coombes RH, Meek EC, Dail MB, Chambers HW, Chambers JE.
    Toxicol Lett; 2014 Oct 01; 230(1):57-61. PubMed ID: 25093614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.
    Furlong CE, Cole TB, Jarvik GP, Pettan-Brewer C, Geiss GK, Richter RJ, Shih DM, Tward AD, Lusis AJ, Costa LG.
    Neurotoxicology; 2005 Aug 01; 26(4):651-9. PubMed ID: 16112327
    [Abstract] [Full Text] [Related]

  • 16. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
    Costa LG, Giordano G, Cole TB, Marsillach J, Furlong CE.
    Toxicology; 2013 May 10; 307():115-22. PubMed ID: 22884923
    [Abstract] [Full Text] [Related]

  • 17. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE.
    Nat Genet; 1996 Nov 10; 14(3):334-6. PubMed ID: 8896566
    [Abstract] [Full Text] [Related]

  • 18. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ.
    Neurotoxicology; 1998 Nov 10; 19(4-5):645-50. PubMed ID: 9745924
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal nematode infection increases organophosphate toxicity in rats.
    Farid AS, Horii Y.
    Toxicol Lett; 2008 Jul 30; 180(1):33-7. PubMed ID: 18577432
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.